401k Plan data: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN plan

INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 401k Plan overview

Plan Name	INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN
Plan identification number	002

INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

INTEGRATED BIOPHARMA, INC. has sponsored the creation of one or more 401k plans.

Company Name: INTEGRATED BIOPHARMA, INC.

Employer identification number (EIN): 222407475

NAIC Classification: 325900
NAIC Description: Other Chemical Product and Preparation Manufacturing

Form 5500 Filing Information

Submission information for form 5500 for 401k plan INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2022-01-01
002 2021-01-01
002 2020-01-01
002 2019-01-01
002 2018-01-01
002 2017-01-01 CHRISTINA KAY
002 2016-01-01 CHRISTINA KAY
002 2015-01-01 CHRISTINA KAY
002 2014-01-01 CHRISTINA KAY
002 2013-01-01 DINA MASI
002 2012-01-01 CHRISTINA KAY
002 2011-01-01 CHRISTINA KAY 2012-09-20
002 2010-01-01 CHRISTINA KAY
002 2009-01-01 STEVEN GREENBAUM
002 2009-01-01 STEVEN GREENBAUM
002 2008-01-01 STEVEN GREENBAUM

Plan Statistics for INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN

401k plan membership statisitcs for INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN

Measure Date Value
2022: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 55
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 36
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 15
Total of all active and inactive participants 2022-01-01 51
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 51
Number of participants with account balances 2022-01-01 33
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 66
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 41
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 14
Total of all active and inactive participants 2021-01-01 55
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 55
Number of participants with account balances 2021-01-01 38
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 56
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 51
Number of other retired or separated participants entitled to future benefits 2020-01-01 15
Total of all active and inactive participants 2020-01-01 66
Total participants 2020-01-01 66
Number of participants with account balances 2020-01-01 37
2019: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 58
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 41
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 15
Total of all active and inactive participants 2019-01-01 56
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 56
Number of participants with account balances 2019-01-01 34
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 53
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 43
Number of other retired or separated participants entitled to future benefits 2018-01-01 15
Total of all active and inactive participants 2018-01-01 58
Total participants 2018-01-01 58
Number of participants with account balances 2018-01-01 36
2017: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 57
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 39
Number of retired or separated participants receiving benefits 2017-01-01 1
Number of other retired or separated participants entitled to future benefits 2017-01-01 13
Total of all active and inactive participants 2017-01-01 53
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 53
Number of participants with account balances 2017-01-01 36
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 58
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 43
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 14
Total of all active and inactive participants 2016-01-01 57
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 57
Number of participants with account balances 2016-01-01 38
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 61
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 41
Number of retired or separated participants receiving benefits 2015-01-01 1
Number of other retired or separated participants entitled to future benefits 2015-01-01 16
Total of all active and inactive participants 2015-01-01 58
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 58
Number of participants with account balances 2015-01-01 42
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 61
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 44
Number of retired or separated participants receiving benefits 2014-01-01 1
Number of other retired or separated participants entitled to future benefits 2014-01-01 16
Total of all active and inactive participants 2014-01-01 61
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 61
Number of participants with account balances 2014-01-01 46
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 84
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 42
Number of retired or separated participants receiving benefits 2013-01-01 1
Number of other retired or separated participants entitled to future benefits 2013-01-01 18
Total of all active and inactive participants 2013-01-01 61
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 61
Number of participants with account balances 2013-01-01 49
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 44
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 53
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 31
Total of all active and inactive participants 2012-01-01 84
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 84
Number of participants with account balances 2012-01-01 60
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2010: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year 2010-01-01 102
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 53
Number of retired or separated participants receiving benefits 2010-01-01 3
Number of other retired or separated participants entitled to future benefits 2010-01-01 37
Total of all active and inactive participants 2010-01-01 93
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 93
Number of participants with account balances 2010-01-01 64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 0
2009: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 123
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 54
Number of retired or separated participants receiving benefits 2009-01-01 3
Number of other retired or separated participants entitled to future benefits 2009-01-01 45
Total of all active and inactive participants 2009-01-01 102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 102
Number of participants with account balances 2009-01-01 74
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 2
2008: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2008 401k membership
Total participants, beginning-of-year 2008-01-01 129
Total number of active participants reported on line 7a of the Form 5500 2008-01-01 99
Number of retired or separated participants receiving benefits 2008-01-01 2
Number of other retired or separated participants entitled to future benefits 2008-01-01 22
Total of all active and inactive participants 2008-01-01 123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2008-01-01 0
Total participants 2008-01-01 123
Number of participants with account balances 2008-01-01 86
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2008-01-01 2

Measure	Date	Value
2022: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	55
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	36
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	15
Total of all active and inactive participants	2022-01-01	51
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	51
Number of participants with account balances	2022-01-01	33
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	66
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	41
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	14
Total of all active and inactive participants	2021-01-01	55
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	55
Number of participants with account balances	2021-01-01	38
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	56
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	51
Number of other retired or separated participants entitled to future benefits	2020-01-01	15
Total of all active and inactive participants	2020-01-01	66
Total participants	2020-01-01	66
Number of participants with account balances	2020-01-01	37
2019: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	58
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	41
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	15
Total of all active and inactive participants	2019-01-01	56
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	56
Number of participants with account balances	2019-01-01	34
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	53
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	43
Number of other retired or separated participants entitled to future benefits	2018-01-01	15
Total of all active and inactive participants	2018-01-01	58
Total participants	2018-01-01	58
Number of participants with account balances	2018-01-01	36
2017: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	57
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	39
Number of retired or separated participants receiving benefits	2017-01-01	1
Number of other retired or separated participants entitled to future benefits	2017-01-01	13
Total of all active and inactive participants	2017-01-01	53
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	53
Number of participants with account balances	2017-01-01	36
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	58
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	43
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	14
Total of all active and inactive participants	2016-01-01	57
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	57
Number of participants with account balances	2016-01-01	38
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	61
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	41
Number of retired or separated participants receiving benefits	2015-01-01	1
Number of other retired or separated participants entitled to future benefits	2015-01-01	16
Total of all active and inactive participants	2015-01-01	58
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	58
Number of participants with account balances	2015-01-01	42
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	61
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	44
Number of retired or separated participants receiving benefits	2014-01-01	1
Number of other retired or separated participants entitled to future benefits	2014-01-01	16
Total of all active and inactive participants	2014-01-01	61
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	61
Number of participants with account balances	2014-01-01	46
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	84
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	42
Number of retired or separated participants receiving benefits	2013-01-01	1
Number of other retired or separated participants entitled to future benefits	2013-01-01	18
Total of all active and inactive participants	2013-01-01	61
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	61
Number of participants with account balances	2013-01-01	49
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	44
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	53
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	31
Total of all active and inactive participants	2012-01-01	84
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	84
Number of participants with account balances	2012-01-01	60
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2010: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2010 401k membership
Total participants, beginning-of-year	2010-01-01	102
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	53
Number of retired or separated participants receiving benefits	2010-01-01	3
Number of other retired or separated participants entitled to future benefits	2010-01-01	37
Total of all active and inactive participants	2010-01-01	93
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	93
Number of participants with account balances	2010-01-01	64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	0
2009: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	123
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	54
Number of retired or separated participants receiving benefits	2009-01-01	3
Number of other retired or separated participants entitled to future benefits	2009-01-01	45
Total of all active and inactive participants	2009-01-01	102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	102
Number of participants with account balances	2009-01-01	74
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	2
2008: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2008 401k membership
Total participants, beginning-of-year	2008-01-01	129
Total number of active participants reported on line 7a of the Form 5500	2008-01-01	99
Number of retired or separated participants receiving benefits	2008-01-01	2
Number of other retired or separated participants entitled to future benefits	2008-01-01	22
Total of all active and inactive participants	2008-01-01	123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2008-01-01	0
Total participants	2008-01-01	123
Number of participants with account balances	2008-01-01	86
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2008-01-01	2

Financial Data on INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN

Measure	Date	Value
2022 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2022 401k financial data
Transfers to/from the plan	2022-12-31	$0
Total plan liabilities at end of year	2022-12-31	$0
Total plan liabilities at beginning of year	2022-12-31	$0
Total income from all sources	2022-12-31	$-1,321,993
Expenses. Total of all expenses incurred	2022-12-31	$69,013
Benefits paid (including direct rollovers)	2022-12-31	$67,878
Total plan assets at end of year	2022-12-31	$6,879,297
Total plan assets at beginning of year	2022-12-31	$8,270,303
Value of fidelity bond covering the plan	2022-12-31	$500,000
Assets. Value of tangible personal property	2022-12-31	$0
Total contributions received or receivable from participants	2022-12-31	$188,226
Assets. Value of loans (other than to participants)	2022-12-31	$0
Expenses. Other expenses not covered elsewhere	2022-12-31	$0
Contributions received from other sources (not participants or employers)	2022-12-31	$0
Other income received	2022-12-31	$-1,574,747
Noncash contributions received	2022-12-31	$0
Net income (gross income less expenses)	2022-12-31	$-1,391,006
Net plan assets at end of year (total assets less liabilities)	2022-12-31	$6,879,297
Net plan assets at beginning of year (total assets less liabilities)	2022-12-31	$8,270,303
Assets. Value of participant loans	2022-12-31	$8,127
Assets. Value of assets in partnership/joint-venture interests	2022-12-31	$0
Assets. Value of real-estate (other than employer real property)	2022-12-31	$0
Assets. Value of employer securities	2022-12-31	$0
Assets. Value of employer real property	2022-12-31	$0
Total contributions received or receivable from employer(s)	2022-12-31	$64,528
Value of certain deemed distributions of participant loans	2022-12-31	$0
Value of corrective distributions	2022-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2022-12-31	$1,135
2021 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2021 401k financial data
Transfers to/from the plan	2021-12-31	$0
Total plan liabilities at end of year	2021-12-31	$0
Total plan liabilities at beginning of year	2021-12-31	$0
Total income from all sources	2021-12-31	$1,333,758
Expenses. Total of all expenses incurred	2021-12-31	$60,811
Benefits paid (including direct rollovers)	2021-12-31	$59,730
Total plan assets at end of year	2021-12-31	$8,270,303
Total plan assets at beginning of year	2021-12-31	$6,997,356
Value of fidelity bond covering the plan	2021-12-31	$500,000
Assets. Value of tangible personal property	2021-12-31	$0
Total contributions received or receivable from participants	2021-12-31	$162,078
Assets. Value of loans (other than to participants)	2021-12-31	$0
Expenses. Other expenses not covered elsewhere	2021-12-31	$0
Contributions received from other sources (not participants or employers)	2021-12-31	$0
Other income received	2021-12-31	$1,073,822
Noncash contributions received	2021-12-31	$0
Net income (gross income less expenses)	2021-12-31	$1,272,947
Net plan assets at end of year (total assets less liabilities)	2021-12-31	$8,270,303
Net plan assets at beginning of year (total assets less liabilities)	2021-12-31	$6,997,356
Assets. Value of participant loans	2021-12-31	$15,807
Assets. Value of assets in partnership/joint-venture interests	2021-12-31	$0
Assets. Value of real-estate (other than employer real property)	2021-12-31	$0
Assets. Value of employer securities	2021-12-31	$0
Assets. Value of employer real property	2021-12-31	$0
Total contributions received or receivable from employer(s)	2021-12-31	$97,858
Value of certain deemed distributions of participant loans	2021-12-31	$0
Value of corrective distributions	2021-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2021-12-31	$1,081
2020 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2020 401k financial data
Transfers to/from the plan	2020-12-31	$0
Total plan liabilities at end of year	2020-12-31	$0
Total plan liabilities at beginning of year	2020-12-31	$0
Total income from all sources	2020-12-31	$1,444,310
Expenses. Total of all expenses incurred	2020-12-31	$38,489
Benefits paid (including direct rollovers)	2020-12-31	$37,464
Total plan assets at end of year	2020-12-31	$6,997,356
Total plan assets at beginning of year	2020-12-31	$5,591,535
Value of fidelity bond covering the plan	2020-12-31	$500,000
Assets. Value of tangible personal property	2020-12-31	$0
Total contributions received or receivable from participants	2020-12-31	$144,986
Assets. Value of loans (other than to participants)	2020-12-31	$0
Expenses. Other expenses not covered elsewhere	2020-12-31	$0
Contributions received from other sources (not participants or employers)	2020-12-31	$50,164
Other income received	2020-12-31	$1,179,812
Noncash contributions received	2020-12-31	$0
Net income (gross income less expenses)	2020-12-31	$1,405,821
Net plan assets at end of year (total assets less liabilities)	2020-12-31	$6,997,356
Net plan assets at beginning of year (total assets less liabilities)	2020-12-31	$5,591,535
Assets. Value of participant loans	2020-12-31	$16,347
Assets. Value of assets in partnership/joint-venture interests	2020-12-31	$0
Assets. Value of real-estate (other than employer real property)	2020-12-31	$0
Assets. Value of employer securities	2020-12-31	$0
Assets. Value of employer real property	2020-12-31	$0
Total contributions received or receivable from employer(s)	2020-12-31	$69,348
Value of certain deemed distributions of participant loans	2020-12-31	$0
Value of corrective distributions	2020-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2020-12-31	$1,025
2019 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2019 401k financial data
Transfers to/from the plan	2019-12-31	$0
Total plan liabilities at end of year	2019-12-31	$0
Total plan liabilities at beginning of year	2019-12-31	$0
Total income from all sources	2019-12-31	$1,311,039
Expenses. Total of all expenses incurred	2019-12-31	$140,518
Benefits paid (including direct rollovers)	2019-12-31	$139,280
Total plan assets at end of year	2019-12-31	$5,591,535
Total plan assets at beginning of year	2019-12-31	$4,421,014
Value of fidelity bond covering the plan	2019-12-31	$500,000
Total contributions received or receivable from participants	2019-12-31	$138,155
Expenses. Other expenses not covered elsewhere	2019-12-31	$0
Contributions received from other sources (not participants or employers)	2019-12-31	$0
Other income received	2019-12-31	$1,103,540
Noncash contributions received	2019-12-31	$0
Net income (gross income less expenses)	2019-12-31	$1,170,521
Net plan assets at end of year (total assets less liabilities)	2019-12-31	$5,591,535
Net plan assets at beginning of year (total assets less liabilities)	2019-12-31	$4,421,014
Assets. Value of participant loans	2019-12-31	$10,278
Total contributions received or receivable from employer(s)	2019-12-31	$69,344
Value of certain deemed distributions of participant loans	2019-12-31	$0
Value of corrective distributions	2019-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2019-12-31	$1,238
2018 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2018 401k financial data
Transfers to/from the plan	2018-12-31	$0
Total plan liabilities at end of year	2018-12-31	$0
Total plan liabilities at beginning of year	2018-12-31	$0
Total income from all sources	2018-12-31	$-127,612
Expenses. Total of all expenses incurred	2018-12-31	$589,478
Benefits paid (including direct rollovers)	2018-12-31	$588,215
Total plan assets at end of year	2018-12-31	$4,421,014
Total plan assets at beginning of year	2018-12-31	$5,138,104
Value of fidelity bond covering the plan	2018-12-31	$500,000
Total contributions received or receivable from participants	2018-12-31	$141,312
Expenses. Other expenses not covered elsewhere	2018-12-31	$0
Contributions received from other sources (not participants or employers)	2018-12-31	$0
Other income received	2018-12-31	$-335,729
Noncash contributions received	2018-12-31	$0
Net income (gross income less expenses)	2018-12-31	$-717,090
Net plan assets at end of year (total assets less liabilities)	2018-12-31	$4,421,014
Net plan assets at beginning of year (total assets less liabilities)	2018-12-31	$5,138,104
Assets. Value of participant loans	2018-12-31	$11,543
Total contributions received or receivable from employer(s)	2018-12-31	$66,805
Value of certain deemed distributions of participant loans	2018-12-31	$0
Value of corrective distributions	2018-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2018-12-31	$1,263
2017 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2017 401k financial data
Transfers to/from the plan	2017-12-31	$0
Total plan liabilities at end of year	2017-12-31	$0
Total plan liabilities at beginning of year	2017-12-31	$0
Total income from all sources	2017-12-31	$978,349
Expenses. Total of all expenses incurred	2017-12-31	$343,254
Benefits paid (including direct rollovers)	2017-12-31	$341,454
Total plan assets at end of year	2017-12-31	$5,138,104
Total plan assets at beginning of year	2017-12-31	$4,503,009
Value of fidelity bond covering the plan	2017-12-31	$500,000
Assets. Value of tangible personal property	2017-12-31	$0
Total contributions received or receivable from participants	2017-12-31	$129,718
Assets. Value of loans (other than to participants)	2017-12-31	$0
Expenses. Other expenses not covered elsewhere	2017-12-31	$0
Contributions received from other sources (not participants or employers)	2017-12-31	$0
Other income received	2017-12-31	$782,334
Noncash contributions received	2017-12-31	$0
Net income (gross income less expenses)	2017-12-31	$635,095
Net plan assets at end of year (total assets less liabilities)	2017-12-31	$5,138,104
Net plan assets at beginning of year (total assets less liabilities)	2017-12-31	$4,503,009
Assets. Value of participant loans	2017-12-31	$20,233
Assets. Value of assets in partnership/joint-venture interests	2017-12-31	$0
Assets. Value of real-estate (other than employer real property)	2017-12-31	$0
Assets. Value of employer securities	2017-12-31	$0
Assets. Value of employer real property	2017-12-31	$0
Total contributions received or receivable from employer(s)	2017-12-31	$66,297
Value of certain deemed distributions of participant loans	2017-12-31	$0
Value of corrective distributions	2017-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2017-12-31	$1,800
2016 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2016 401k financial data
Transfers to/from the plan	2016-12-31	$0
Total plan liabilities at end of year	2016-12-31	$0
Total plan liabilities at beginning of year	2016-12-31	$0
Total income from all sources	2016-12-31	$512,834
Expenses. Total of all expenses incurred	2016-12-31	$507,768
Benefits paid (including direct rollovers)	2016-12-31	$506,112
Total plan assets at end of year	2016-12-31	$4,503,009
Total plan assets at beginning of year	2016-12-31	$4,497,943
Value of fidelity bond covering the plan	2016-12-31	$500,000
Total contributions received or receivable from participants	2016-12-31	$130,129
Expenses. Other expenses not covered elsewhere	2016-12-31	$0
Contributions received from other sources (not participants or employers)	2016-12-31	$0
Other income received	2016-12-31	$320,350
Noncash contributions received	2016-12-31	$0
Net income (gross income less expenses)	2016-12-31	$5,066
Net plan assets at end of year (total assets less liabilities)	2016-12-31	$4,503,009
Net plan assets at beginning of year (total assets less liabilities)	2016-12-31	$4,497,943
Assets. Value of participant loans	2016-12-31	$34,309
Total contributions received or receivable from employer(s)	2016-12-31	$62,355
Value of certain deemed distributions of participant loans	2016-12-31	$0
Value of corrective distributions	2016-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2016-12-31	$1,656
2015 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2015 401k financial data
Transfers to/from the plan	2015-12-31	$0
Total plan liabilities at end of year	2015-12-31	$0
Total plan liabilities at beginning of year	2015-12-31	$0
Total income from all sources	2015-12-31	$129,264
Expenses. Total of all expenses incurred	2015-12-31	$457,939
Benefits paid (including direct rollovers)	2015-12-31	$455,589
Total plan assets at end of year	2015-12-31	$4,497,943
Total plan assets at beginning of year	2015-12-31	$4,826,618
Value of fidelity bond covering the plan	2015-12-31	$500,000
Total contributions received or receivable from participants	2015-12-31	$130,339
Expenses. Other expenses not covered elsewhere	2015-12-31	$0
Contributions received from other sources (not participants or employers)	2015-12-31	$0
Other income received	2015-12-31	$-64,074
Noncash contributions received	2015-12-31	$0
Net income (gross income less expenses)	2015-12-31	$-328,675
Net plan assets at end of year (total assets less liabilities)	2015-12-31	$4,497,943
Net plan assets at beginning of year (total assets less liabilities)	2015-12-31	$4,826,618
Assets. Value of participant loans	2015-12-31	$51,557
Total contributions received or receivable from employer(s)	2015-12-31	$62,999
Value of certain deemed distributions of participant loans	2015-12-31	$0
Value of corrective distributions	2015-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2015-12-31	$2,350
2014 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2014 401k financial data
Transfers to/from the plan	2014-12-31	$0
Total plan liabilities at end of year	2014-12-31	$0
Total plan liabilities at beginning of year	2014-12-31	$0
Total income from all sources	2014-12-31	$500,741
Expenses. Total of all expenses incurred	2014-12-31	$437,118
Benefits paid (including direct rollovers)	2014-12-31	$434,950
Total plan assets at end of year	2014-12-31	$4,826,618
Total plan assets at beginning of year	2014-12-31	$4,762,995
Value of fidelity bond covering the plan	2014-12-31	$500,000
Total contributions received or receivable from participants	2014-12-31	$143,744
Expenses. Other expenses not covered elsewhere	2014-12-31	$0
Contributions received from other sources (not participants or employers)	2014-12-31	$0
Other income received	2014-12-31	$286,332
Noncash contributions received	2014-12-31	$0
Net income (gross income less expenses)	2014-12-31	$63,623
Net plan assets at end of year (total assets less liabilities)	2014-12-31	$4,826,618
Net plan assets at beginning of year (total assets less liabilities)	2014-12-31	$4,762,995
Assets. Value of participant loans	2014-12-31	$54,887
Total contributions received or receivable from employer(s)	2014-12-31	$70,665
Value of certain deemed distributions of participant loans	2014-12-31	$0
Value of corrective distributions	2014-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2014-12-31	$2,168
2013 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2013 401k financial data
Transfers to/from the plan	2013-12-31	$12,756
Total plan liabilities at end of year	2013-12-31	$0
Total plan liabilities at beginning of year	2013-12-31	$0
Total income from all sources	2013-12-31	$1,068,476
Expenses. Total of all expenses incurred	2013-12-31	$455,828
Benefits paid (including direct rollovers)	2013-12-31	$451,237
Total plan assets at end of year	2013-12-31	$4,762,995
Total plan assets at beginning of year	2013-12-31	$4,137,591
Value of fidelity bond covering the plan	2013-12-31	$500,000
Total contributions received or receivable from participants	2013-12-31	$156,774
Expenses. Other expenses not covered elsewhere	2013-12-31	$0
Contributions received from other sources (not participants or employers)	2013-12-31	$62,487
Other income received	2013-12-31	$795,699
Noncash contributions received	2013-12-31	$0
Net income (gross income less expenses)	2013-12-31	$612,648
Net plan assets at end of year (total assets less liabilities)	2013-12-31	$4,762,995
Net plan assets at beginning of year (total assets less liabilities)	2013-12-31	$4,137,591
Assets. Value of participant loans	2013-12-31	$53,377
Total contributions received or receivable from employer(s)	2013-12-31	$53,516
Value of certain deemed distributions of participant loans	2013-12-31	$0
Value of corrective distributions	2013-12-31	$2,578
Expenses. Administrative service providers (salaries,fees and commissions)	2013-12-31	$2,013
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
2012 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2012 401k financial data
Total income from all sources	2012-12-31	$434,113
Expenses. Total of all expenses incurred	2012-12-31	$455,419
Benefits paid (including direct rollovers)	2012-12-31	$454,819
Total plan assets at end of year	2012-12-31	$4,137,591
Total plan assets at beginning of year	2012-12-31	$4,158,897
Value of fidelity bond covering the plan	2012-12-31	$500,000
Total contributions received or receivable from participants	2012-12-31	$97,913
Other income received	2012-12-31	$336,200
Net income (gross income less expenses)	2012-12-31	$-21,306
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$4,137,591
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$4,158,897
Assets. Value of participant loans	2012-12-31	$43,362
Expenses. Administrative service providers (salaries,fees and commissions)	2012-12-31	$600
2010 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$658,798
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$412,892
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$399,191
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$112,726
Value of total assets at end of year	2010-12-31	$4,792,468
Value of total assets at beginning of year	2010-12-31	$4,546,562
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$13,701
Total interest from all sources	2010-12-31	$6,006
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$112,726
Participant contributions at end of year	2010-12-31	$96,081
Participant contributions at beginning of year	2010-12-31	$52,177
Participant contributions at end of year	2010-12-31	$0
Participant contributions at beginning of year	2010-12-31	$10,195
Value of other receiveables (less allowance for doubtful accounts) at end of year	2010-12-31	$33,992
Administrative expenses (other) incurred	2010-12-31	$1,165
Total non interest bearing cash at end of year	2010-12-31	$0
Total non interest bearing cash at beginning of year	2010-12-31	$1
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$245,906
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$4,792,468
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$4,546,562
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Investment advisory and management fees	2010-12-31	$12,536
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$27,835
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$59,450
Value of interest in pooled separate accounts at end of year	2010-12-31	$4,532,635
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$4,292,835
Interest on participant loans	2010-12-31	$4,388
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2010-12-31	$101,925
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2010-12-31	$102,686
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2010-12-31	$102,686
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2010-12-31	$1,618
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2010-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2010-12-31	$0
Asset value of US Government securities at end of year	2010-12-31	$0
Asset value of US Government securities at beginning of year	2010-12-31	$0
Net investment gain/loss from pooled separate accounts	2010-12-31	$540,066
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Employer contributions (assets) at end of year	2010-12-31	$0
Employer contributions (assets) at beginning of year	2010-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$399,191
Assets. Corporate common stocks other than exployer securities at end of year	2010-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2010-12-31	$29,218
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	MURPHY, MILLER & BAGLIERI, LLP
Accountancy firm EIN	2010-12-31	201689274
2008 : INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2008 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2008-12-31	$-83,155
Total unrealized appreciation/depreciation of assets	2008-12-31	$-83,155
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2008-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2008-12-31	$0
Total income from all sources (including contributions)	2008-12-31	$-966,820
Total loss/gain on sale of assets	2008-12-31	$-11,565
Total of all expenses incurred	2008-12-31	$465,948
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2008-12-31	$450,108
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2008-12-31	$887,986
Value of total assets at end of year	2008-12-31	$4,284,647
Value of total assets at beginning of year	2008-12-31	$5,717,415
Total of administrative expenses incurred including professional, contract, advisory and management fees	2008-12-31	$15,840
Total interest from all sources	2008-12-31	$10,205
Total dividends received (eg from common stock, registered investment company shares)	2008-12-31	$4,127
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2008-12-31	No
Was this plan covered by a fidelity bond	2008-12-31	Yes
Value of fidelity bond cover	2008-12-31	$500,000
If this is an individual account plan, was there a blackout period	2008-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2008-12-31	No
Contributions received from participants	2008-12-31	$563,492
Participant contributions at end of year	2008-12-31	$64,829
Participant contributions at beginning of year	2008-12-31	$67,462
Participant contributions at end of year	2008-12-31	$39,019
Participant contributions at beginning of year	2008-12-31	$39,860
Income. Received or receivable in cash from other sources (including rollovers)	2008-12-31	$58,619
Other income not declared elsewhere	2008-12-31	$909
Administrative expenses (other) incurred	2008-12-31	$1,690
Total non interest bearing cash at end of year	2008-12-31	$1
Total non interest bearing cash at beginning of year	2008-12-31	$1
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2008-12-31	No
Value of net income/loss	2008-12-31	$-1,432,768
Value of net assets at end of year (total assets less liabilities)	2008-12-31	$4,284,647
Value of net assets at beginning of year (total assets less liabilities)	2008-12-31	$5,717,415
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2008-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2008-12-31	No
Were any leases to which the plan was party in default or uncollectible	2008-12-31	No
Investment advisory and management fees	2008-12-31	$14,150
Value of interest in registered invesment companies (eg mutual funds) at end of year	2008-12-31	$43,699
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2008-12-31	$43,136
Value of interest in pooled separate accounts at end of year	2008-12-31	$3,997,540
Value of interest in pooled separate accounts at beginning of year	2008-12-31	$5,207,553
Interest on participant loans	2008-12-31	$6,293
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2008-12-31	$96,669
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2008-12-31	$90,309
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2008-12-31	$90,309
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2008-12-31	$3,912
Asset value of US Government securities at end of year	2008-12-31	$0
Asset value of US Government securities at beginning of year	2008-12-31	$25,024
Net investment gain/loss from pooled separate accounts	2008-12-31	$-1,775,327
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2008-12-31	No
Was there a failure to transmit to the plan any participant contributions	2008-12-31	No
Has the plan failed to provide any benefit when due under the plan	2008-12-31	No
Contributions received in cash from employer	2008-12-31	$265,875
Employer contributions (assets) at end of year	2008-12-31	$17,157
Employer contributions (assets) at beginning of year	2008-12-31	$20,299
Income. Dividends from common stock	2008-12-31	$4,127
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2008-12-31	$450,108
Assets. Corporate common stocks other than exployer securities at end of year	2008-12-31	$25,733
Assets. Corporate common stocks other than exployer securities at beginning of year	2008-12-31	$223,771
Did the plan have assets held for investment	2008-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2008-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2008-12-31	No
Aggregate proceeds on sale of assets	2008-12-31	$25,236
Aggregate carrying amount (costs) on sale of assets	2008-12-31	$36,801
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2008-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2008-12-31	Disclaimer
Accountancy firm name	2008-12-31	MURPHY, MILLER & BAGLIERI, LLP
Accountancy firm EIN	2008-12-31	201689274

Form 5500 Responses for INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN

2022: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2010: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	Yes
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Insurance	Yes
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement – Insurance	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement – Insurance	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes
2008: INTEGRATED BIOPHARMA, INC. EMPLOYEES' PROFIT SHARING PLAN 2008 form 5500 responses
2008-01-01	Type of plan entity	Single employer plan
2008-01-01	Submission has been amended	Yes
2008-01-01	This submission is the final filing	No
2008-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2008-01-01	Plan is a collectively bargained plan	No
2008-01-01	Plan funding arrangement – Insurance	Yes
2008-01-01	Plan funding arrangement – Trust	Yes
2008-01-01	Plan benefit arrangement – Insurance	Yes
2008-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

332387-01

Policy instance

Insurance contract or identification number	332387-01
Number of Individuals Covered	0
Insurance policy start date	2013-01-01
Insurance policy end date	2013-11-13
Total amount of commissions paid to insurance broker	USD $829
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $678
Amount paid for insurance broker fees	678
Insurance broker organization code?	3
Insurance broker name	BRAD GREENBAUM

GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 68322 )

Policy contract number

332387-01

Policy instance

Insurance contract or identification number	332387-01
Number of Individuals Covered	11
Insurance policy start date	2012-01-01
Insurance policy end date	2012-12-31
Total amount of commissions paid to insurance broker	USD $9,134
Commission paid to Insurance Broker	USD $9,134
Insurance broker organization code?	3
Insurance broker name	BRAD GREENBAUM

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

20912

Policy instance

Insurance contract or identification number	20912
Number of Individuals Covered	64
Insurance policy start date	2010-01-01
Insurance policy end date	2010-12-31
Total amount of commissions paid to insurance broker	USD $10,942
Total amount of fees paid to insurance company	USD $3,288
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

20912

Policy instance

Insurance contract or identification number	20912
Number of Individuals Covered	88
Insurance policy start date	2008-01-01
Insurance policy end date	2008-12-31
Total amount of commissions paid to insurance broker	USD $12,674
Total amount of fees paid to insurance company	USD $3,509
Are there contracts with allocated funds for individual policies?	No
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Commission paid to Insurance Broker	USD $12,674
Insurance broker organization code?	3
Amount paid for insurance broker fees	2609
Additional information about fees paid to insurance broker	TPA COMPENSATION
Insurance broker name	ALTIGRO PENSION SERVICES, INC.

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	INTEGRATED BIOPHARMA, INC.
Employer identification number (EIN):	222407475
NAIC Classification:	325900
NAIC Description:	Other Chemical Product and Preparation Manufacturing